Joshua Bueller
Overview
Explore the profile of Joshua Bueller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Labus J, Hubbard C, Bueller J, Ebrat B, Tillisch K, Chen M, et al.
Gastroenterology
. 2013 Aug;
145(6):1253-61.e1-3.
PMID: 23954313
Background & Aims: Alterations in central corticotropin-releasing factor signaling pathways have been implicated in the pathophysiology of anxiety disorders and irritable bowel syndrome (IBS). We aimed to characterize the effects...
2.
Labus J, Gupta A, Coveleskie K, Tillisch K, Kilpatrick L, Jarcho J, et al.
Pain
. 2013 Jun;
154(10):2088-2099.
PMID: 23791896
Greater responsiveness of emotional arousal circuits in relation to delivered visceral pain has been implicated as underlying central pain amplification in irritable bowel syndrome (IBS), with female subjects showing greater...
3.
Berman S, Suyenobu B, Naliboff B, Bueller J, Stains J, Wong H, et al.
Neuroimage
. 2012 Aug;
63(4):1854-63.
PMID: 22917679
Background/aims: Alterations in noradrenergic (NE) signaling have been implicated in the pathophysiology of irritable bowel syndrome (IBS), and adrenergic receptors are potential treatment targets. Methods: To characterize central NE signaling...
4.
Hubbard C, Labus J, Bueller J, Stains J, Suyenobu B, Dukes G, et al.
J Neurosci
. 2011 Sep;
31(35):12491-500.
PMID: 21880911
Alterations in corticotropin-releasing factor (CRF) signaling pathways have been implicated in irritable bowel syndrome (IBS) pathophysiology. We aimed to (1) determine the effect of the selective CRF receptor 1 antagonist...
5.
Greenwald M, Johanson C, Bueller J, Chang Y, Moody D, Kilbourn M, et al.
Biol Psychiatry
. 2006 Sep;
61(1):101-10.
PMID: 16950210
Background: Buprenorphine (BUP) is effective in the treatment of opioid dependence when given on alternating days, probably as a result of long-lasting occupation of micro opioid receptors (microORs). This study...